Clinical Trials Insight: 700050903

Trial Profile

Clinical Trials Insight: 700050903

Phase of Trial: Phase III

Latest Information Update: 01 Jun 2012

At a glance

  • Drugs Dienogest (Primary) ; Leuprorelin
  • Indications Endometriosis; Pelvic pain
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Bayer HealthCare Pharmaceuticals
  • Most Recent Events

    • 01 Jun 2012 Results published in the International Journal of Gynaecology and Obstetrics.
    • 01 Mar 2010 Results published in Human Reproduction.
    • 11 Nov 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top